Impact of NAD(P)H:Quinone oxidoreductase-1 on pigmentation

Journal of Investigative Dermatology

Volumn 130, Issue 3, 2010, Pages 784-792

  Choi, Tae Young ^a   Sohn, Kyung Cheol ^a   Kim, Jin Hwa ^b   Kim, Seong Min ^b   Kim, Cheol Hee ^c   Hwang, Jae Sung ^d   Lee, Jeung Hoon ^a   Kim, Chang Deok ^a   Yoon, Tae Jin ^b  

^a Chungnam National University College of Medicine   (South Korea)

^b Gyeongsang National University School of Medicine   (South Korea)

^c Chungnam National University   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DICOUMAROL; ES 936; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; NADPH:QUINONE OXIREDUCTASE 1; OXIDOREDUCTASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; TYROSINASE RELATED PROTEIN 1; UNCLASSIFIED DRUG;

ACRAL LENTIGINOUS MELANOMA; AMELANOTIC MELANOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MELANOGENESIS; MELANOMA; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN PIGMENTATION; WESTERN BLOTTING; ZEBRA FISH;

EID: 76649127405     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.280     Document Type: Article

References (29)

1. Anwar A, Dehn D, Siegel D, Kepa JK, Tang LJ, Pietenpol JA et al. (2003) Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J Biol Chem 278:10368-10373
2. Asher G, Bercovich Z, Tsvetkov P, Shaul Y, Kahana C (2005) 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. Mol Cell 17:645-655
3. Asher G, Dym O, Tsvetkov P, Adler J, Shaul Y (2006) The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Biochemistry 45:6372-6378
4. Choi TY, Kim JH, Ko DH, Kim CH, Hwang JS, Ahn S et al. (2007) Zebrafish as a new model for phenotype-based screening of melanogenic regulatory compounds. Pigment Cell Res 20:120-127
5. Costin GE, Hearing VJ (2007) Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB J 21:976-994
6. Cullen JJ, Hinkhouse MM, Grady M, Gaut AW, Liu J, Zhang YP et al. (2003) Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism. Cancer Res 63:5513-5520
7. Dehn DL, Siegel D, Swann E, Moody CJ, Ross D (2003) Biochemical, cytotoxic, and genotoxic effects of ES936, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, in cellular systems. Mol Pharmacol 64:714-720
8. Gasdaska PY, Fisher H, Powis G (1995) An alternatively spliced form of NQO1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues. Cancer Res 55:2542-2547
9. Gong X, Kole L, Iskander K, Jaiswal AK (2007) NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20 seconds proteasomal degradation leading to stabilization and activation of p53. Cancer Res 67:5380-5388
10. Garate M, Wong RP, Campos EI, Wang Y, Li G (2008) NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b). EMBO Rep 9:576-581
11. Jaiswal AK, McBride OW, Adesnik M, Nebert DW (1988) Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16. J Biol Chem 263:13572-13578
12. Land EJ, Ramsden CA, Riley PA (2004) Quinone chemistry and melanogen-esis. Methods Enzymol 378:88-109
13. Lind C, Cadenas E, Hochstein P, Ernster L (1990) DT-diaphorase: purification, properties, and function. Methods Enzymol 186:287-301
14. Long DJ II, Waikel RL, Wang XJ, Roop DR, Jaiswal AK (2001) NAD(P)H: quinone oxidoreductase 1 deficiency and increased susceptibility to 7, 12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. J Natl Cancer Inst 93:1166-1170
15. Long DJ II, Waikel RL, Wang XJ, Perlaky L, Roop DR, Jaiswal AK (2000) NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Res 60:5913-5915
16. Marrot L, Jones C, Perez P, Meunier JR (2008) The significance of Nrf2 pathway in (photo)-oxidative stress response in melanocytes and keratinocytes of the human epidermis. Pigment Cell Melanoma Res 21:79-88
17. Miller AJ, Mihm MC Jr (2006) Melanoma. N Engl J Med 355:51-65
18. Nioi P, Hayes JD (2004) Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat Res 555:149-171
19. Phan A, Touzet S, Dalle S, Ronger-Savle S, Balme B, Thomas L (2006) Acral lentiginous melanoma: a clinicoprognostic study of 126 cases. Br J Dermatol 155:561-569
20. Riley RJ, Workman P (1992) DT-diaphorase and cancer chemotherapy. Biochem Pharmacol 43:1657-1669
21. Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D (2000) NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioac-tivation, gene regulation and genetic polymorphisms. Chem Biol Interact 129:77-97
22. Schallreuter KU, Kothari S, Chavan B, Spencer JD (2008) Regulation of melanogenesis-controversies and new concepts. Exp Dermatol 17:395-404
23. Seo EY, Namkung JH, Lee KM, Lee WH, Im M, Kee SH et al. (2005) Analysis of calcium-inducible genes in keratinocytes using suppression subtrac-tive hybridization and cDNA microarray. Genomics 86:528-538
24. Tollefson AE, Kuppuswamy M, Shashkova EV, Doronin K, Wold WS (2007) Preparation and titration of CsCl-banded adenovirus stocks. Methods Mol Med 130:223-235
25. Wang N, Hebert DN (2006) Tyrosinase maturation through the mammalian secretory pathway: bringing color to life. Pigment Cell Res 19:3-18
26. Winski SL, Swann E, Hargreaves RH, Dehn DL, Butler J, Moody CJ et al. (2001) Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones. Biochem Pharmacol 61:1509-1516
27. Wood JM, Schallreuter KU (2008) A plaidoyer for cutaneous enzymology: our view of some important unanswered questions on the contributions of selected key enzymes to epidermal homeostasis. Exp Dermatol 17:569-578
28. Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, Kim YS et al. (2006) Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 8:1074-1083
29. Yoon HK, Sohn KC, Lee JS, Kim YJ, Bhak J, Yang JM et al. (2008) Prediction and evaluation of protein-protein interaction in keratinocyte differentiation. Biochem Biophys Res Commun 377:662-667